
Congratulations to Dr. Alan P. Kumar on the publication of his newly edited book on CRISPR/Cas9 and cancer research.
This book brings together leading international perspectives on how CRISPR/Cas9 gene-editing technology is transforming cancer research and redefining therapeutic possibilities. Covering advances from fundamental mechanistic insights to translational applications, the volume highlights the growing importance of genome editing as a cornerstone of next-generation oncology.
A central focus of the book is drug resistance, one of the most pressing challenges in cancer treatment. Several chapters examine how CRISPR/Cas9 is being applied to dissect genetic mechanisms underlying therapeutic resistance, offering new strategies to address treatment failure, particularly in patients who have exhausted conventional options.
For more details:Â https://www.worldscientific.com/worldscibooks/10.1142/14690#t=aboutBook
